| Year |
Citation |
Score |
| 2015 |
Cáceda R, James GA, Gutman DA, Kilts CD. Organization of intrinsic functional brain connectivity predicts decisions to reciprocate social behavior. Behavioural Brain Research. 292: 478-83. PMID 26166191 DOI: 10.1016/j.bbr.2015.07.008 |
0.611 |
|
| 2015 |
Rios Velazquez E, Meier R, Dunn W, Alexander B, Wiest R, Bauer S, Gutman D, Reyes M, Aerts H. TU-AB-BRA-11: Evaluation of Fully Automatic Volumetric GBM Segmentation in the TCGA-GBM Dataset: Prognosis and Correlation with VASARI Features Medical Physics. 42: 3589-3589. DOI: 10.1118/1.4925516 |
0.309 |
|
| 2014 |
Nemeth CL, Gutman DA, Majeed W, Keilholz SD, Neigh GN. Microembolism induces anhedonia but no detectable changes in white matter integrity in aged rats. Plos One. 9: e96624. PMID 24811070 DOI: 10.1371/journal.pone.0096624 |
0.566 |
|
| 2014 |
Stevens JS, Almli LM, Fani N, Gutman DA, Bradley B, Norrholm SD, Reiser E, Ely TD, Dhanani R, Glover EM, Jovanovic T, Ressler KJ. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 111: 3158-63. PMID 24516127 DOI: 10.1073/Pnas.1318954111 |
0.32 |
|
| 2013 |
Fani N, Gutman D, Tone EB, Almli L, Mercer KB, Davis J, Glover E, Jovanovic T, Bradley B, Dinov ID, Zamanyan A, Toga AW, Binder EB, Ressler KJ. FKBP5 and attention bias for threat: associations with hippocampal function and shape. Jama Psychiatry. 70: 392-400. PMID 23407841 DOI: 10.1001/2013.Jamapsychiatry.210 |
0.482 |
|
| 2011 |
Gutman DA, Owens MJ, Thrivikraman KV, Nemeroff CB. Persistent anxiolytic affects after chronic administration of the CRFâ‚ receptor antagonist R121919 in rats. Neuropharmacology. 60: 1135-41. PMID 20951149 DOI: 10.1016/j.neuropharm.2010.10.004 |
0.638 |
|
| 2010 |
Gutman DA, Nemeroff CB. Corticotropin-Releasing Factor Circuitry in the Brain - Relevance for Affective Disorders and Anxiety Encyclopedia of Stress. 630-634. DOI: 10.1016/B978-012373947-6.00454-2 |
0.347 |
|
| 2009 |
Gutman DA, Coyer MJ, Boss-Williams KA, Owens MJ, Nemeroff CB, Weiss JM. Erratum to “Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test” [Psychoneuroendocrinology 33(8) (2008) 1093–1101] Psychoneuroendocrinology. 34: 630-631. DOI: 10.1016/j.psyneuen.2009.01.008 |
0.599 |
|
| 2008 |
Gutman DA, Coyer MJ, Boss-Williams KA, Owens MJ, Nemeroff CB, Weiss JM. Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test. Psychoneuroendocrinology. 33: 1093-101. PMID 18676086 DOI: 10.1016/j.psyneuen.2008.05.003 |
0.601 |
|
| 2007 |
Skelton KH, Oren D, Gutman DA, Easterling K, Holtzman SG, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. European Journal of Pharmacology. 571: 17-24. PMID 17610870 DOI: 10.1016/j.ejphar.2007.05.041 |
0.752 |
|
| 2007 |
Skelton KH, Gutman DA, Thrivikraman KV, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology. 192: 385-96. PMID 17297634 DOI: 10.1007/s00213-007-0713-3 |
0.75 |
|
| 2006 |
Gutman DA, Owens MJ. Serotonin and norepinephrine transporter binding profile of SSRIs. Essential Psychopharmacology. 7: 35-41. PMID 16989291 |
0.416 |
|
| 2006 |
Gutman DA, Gutman AR, Owens MJ, Nemeroff CB. Stress neurobiology and corticotropin-releasing factor Psychiatric Times. 23: 91-95. |
0.531 |
|
| 2004 |
Owens M, Hanson N, Gutman D. S.19.05 Development of molecular targets for understanding and treating stress-related disorders European Neuropsychopharmacology. 14: S148-S149. DOI: 10.1016/S0924-977X(04)80060-9 |
0.429 |
|
| 2003 |
Gutman DA, Nemeroff CB. Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies. Physiology & Behavior. 79: 471-8. PMID 12954441 DOI: 10.1016/S0031-9384(03)00166-5 |
0.448 |
|
| 2003 |
Mandell AJ, Selz KA, Owens MJ, Kinkead B, Shlesinger MF, Gutman DA, Arguragi V. Cellular and behavioral effects of D2 dopamine receptor hydrophobic eigenmode-targeted peptide ligands. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: S98-107. PMID 12827150 DOI: 10.1038/sj.npp.1300134 |
0.658 |
|
| 2003 |
Gutman DA, Owens MJ, Skelton KH, Thrivikraman KV, Nemeroff CB. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. The Journal of Pharmacology and Experimental Therapeutics. 304: 874-80. PMID 12538845 DOI: 10.1124/jpet.102.042788 |
0.746 |
|
| 2002 |
Gutman DA, Nemeroff CB. Neurobiology of early life stress: rodent studies. Seminars in Clinical Neuropsychiatry. 7: 89-95. PMID 11953932 DOI: 10.1053/Scnp.2002.31781 |
0.42 |
|
| 2001 |
Rilling JK, Winslow JT, O'Brien D, Gutman DA, Hoffman JM, Kilts CD. Neural correlates of maternal separation in rhesus monkeys. Biological Psychiatry. 49: 146-57. PMID 11164761 DOI: 10.1016/S0006-3223(00)00977-X |
0.306 |
|
| 2001 |
Owens M, Gutman D. CRF1 receptor antagonists: Long term treatment and efficacy in animal models European Neuropsychopharmacology. 11: S179-S180. DOI: 10.1016/S0924-977X(01)80118-8 |
0.445 |
|
| 2001 |
Gutman DA, Owens MJ, Nemeroff CB. CRF receptor antagonists: A new approach to the treatment of depression Pharmaceutical News. 8: 18-25. |
0.448 |
|
| 2000 |
Gutman D, Owens M, Nemeroff C. Corticotropin-releasing factor antagonists as novel psychotherapeutics Drugs of the Future. 25: 923. DOI: 10.1358/DOF.2000.025.09.665577 |
0.57 |
|
| Show low-probability matches. |